3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gastrointestinal
1
Conditions
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Interventions
Dexamethasone
116
Bortezomib
63
Cyclophosphamide
51
Lenalidomide
49
Calcium Dobesilate
46
Melphalan
37
pomalidomide
36
fludarabine
28
Filgrastim
26
fludarabine phosphate
23
carfilzomib
22
daratumumab
21
Whole-Body Irradiation
17
Granulocyte Colony-Stimulating Factor
17
Mycophenolic Acid
15
Antilymphocyte Serum
15
dexamethasone acetate
14
Tacrolimus
14
Thalidomide
13
Cyclosporine
13
Busulfan
13
Radiotherapy
12
Peripheral Blood Stem Cell Transplantation
12
ixazomib
11
dexamethasone 21-phosphate
10
auricularum
10
pembrolizumab
9
Stem Cell Transplantation
9
Rituximab
9
Etoposide
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Molecular Diagnostic Techniques
×
Plasma cell
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled